Study: Use of PET and PET/CT is cost-effective for some cancers

03/31/2010 | HealthImaging.com

German researchers who examined data from Germany, Britain, other European countries and the U.S. found that on a patient basis, the costs for PET and PET/CT procedures are decreasing with the increase in use of the procedures for certain cancers, including nonsmall-cell lung cancer, Hodgkin's disease, non-Hodgkin's lymphoma and colorectal carcinoma. There still is a need for larger trials to determine the cost-effectiveness of the tests for other cancers, the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA